(1) Thompson MG et al : Interim estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines in preventing SARS-CoV-2 infection among health care personnel, first responders, and other essential and frontline workers-eight U.S. locations, December 2020-March 2021 https://www.cdc.gov/mmwr/volumes/70/wr/pdfs/mm7013e3-H.pdf
(2) Pilishvili T et al : Interim estimates of vaccine effectiveness of Pfizer-BioNTech and Moderna COVID-19 vaccines among health care personnel-33 U. S. sites, January-March 2021 https://www.cdc.gov/mmwr/volumes/70/wr/pdfs/mm7020e2-H.pdf
(3) Tenforde MW et al : Effectiveness of Pfizer-BioNTech and Moderna vaccines against COVID-19 among hospitalized adults aged > 65 Years-United States, January-March 2021 https://www.cdc.gov/mmwr/volumes/70/wr/pdfs/mm7018e1-H.pdf
(4) CDC : COVID-19 : Science brief : COVID-19 vaccines and vaccination https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/fullyvaccinated-people.html
(5) Jones NK et al : Single-dose BNT162b2 vaccine protects against asymptomatic SARS-CoV-2 infection. eLife 10 : e68808, 2021, doi : 10.7554/eLife.68808
(7) McEllistrem MC et al : Single dose of a mRNA SARS-CoV-2 vaccine is associated with lower nasopharyngeal viral load among nursing home residents with asymptomatic COVID-19. Clin Infect Dis, 2021, doi : 10.1093/cid/ciab263
(9) Musser JM et al : Delta variants of SARS-CoV-2 cause significantly increased vaccine breakthrough COVID-19 cases in Houston, Texas. medRxiv, 2021, doi : https://doi.org/10.1101/2021.07.19.21260808
(11) CDC : COVID-19 : Delta variant : What we know about the science https://www.cdc.gov/coronavirus/2019-ncov/variants/delta-variant.html
(13) CDC : Epidemiology and Prevention of Vaccine-Preventable Diseases https://www.cdc.gov/vaccines/pubs/pinkbook/index.html
(15) CDC : Guideline for hand hygiene in health-care settings, 2002 https://www.cdc.gov/mmwr/PDF/rr/rr5116.pdf
(16) WHO : Coronavirus disease (COVID-19) advice for the public : Myth busters https://www.who.int/emergencies/diseases/novel-coronavirus-2019/advice-forpublic/myth-busters
(17) CDC : Guideline for isolation precautions : Preventing transmission of infectious agents in healthcare settings, 2007 https://www.cdc.gov/infectioncontrol/pdf/guidelines/isolation-guidelines-H.pdf
(18) WHO : COVID-19 : physical distancing https://www.who.int/westernpacific/emergencies/covid-19/information/physical-distancing
(19) Unicef : Physical not social distancing https://www.unicef.org/sudan/press-releases/physical-not-social-distancing
(20) CDC : COVID-19 : How to protect yourself & others https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html
(21) 厚生労働省 : 新型コロナウイルスを想定した「新しい生活様式」の実践例を公表しました https://www.mhlw.go.jp/stf/seisakunitsuite/bunya/0000121431_newlifestyle.html
(24) Stutt ROJH et al : A modelling framework to assess the likely effectiveness of facemasks in combination with 'lock-down' in managing the COVID-19 pandemic. http://dx.doi.org/10.1098/rspa.2020.0376
(31) CDC : COVID-19 : Science Brief : SARS-CoV-2 and surface (fomite) transmission for indoor community environments https://www.cdc.gov/coronavirus/2019-ncov/more/science-and-research/surface-transmission.html
(32) EPA : Is there anything I can do to make surfaces resistant to SARS-CoV-2 (COVID-19)? https://www.epa.gov/coronavirus/there-anything-i-can-do-make-surfacesresistant-sars-cov-2-covid-19
(33) CDC : COVID-19 : Considerations for restaurant and bar operators https://www.cdc.gov/coronavirus/2019-ncov/community/organizations/business-employers/bars-restaurants.html
(34) CDC : COVID-19 : Science Brief : Community use of cloth masks to control the spread of SARS-CoV-2 https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/maskingscience-sars-cov2.html